Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Study completedNCT00020917What this trial is testingCetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal CancerWho this might be right forColorectal Cancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00040820What this trial is testingOxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT02757391What this trial is testingCD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsWho this might be right forColorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT03844750What this trial is testingPreoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic MetastasesWho this might be right forMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more Chloe Atreya, MD, PhD 6
Early research (Phase 1)Not Yet RecruitingNCT07363408What this trial is testingIvonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal CancerWho this might be right forAdvanced Microsatellite Stable Colorectal CarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaStage III Colorectal Cancer AJCC v8+1 more City of Hope Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT01880658What this trial is testingPhase II Study of Maintenance Capecitabine to Treat Resectable Colorectal CancerWho this might be right forColorectal Neoplasms Sun Yat-sen University 100
Early research (Phase 1)Ended earlyNCT03515824What this trial is testingStudy of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)Who this might be right forNeoplasmsColorectal NeoplasmsHead and Neck Neoplasms Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Study completedNCT02834052What this trial is testingPembrolizumab + Poly-ICLC in MRP Colon CancerWho this might be right forMetastatic Colon CancerSolid Tumor Asha Nayak 42
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Testing effectiveness (Phase 2)Study completedNCT00217711What this trial is testingOxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryWho this might be right forColorectal Cancer Swiss Cancer Institute 23
Testing effectiveness (Phase 2)UnknownNCT00496704What this trial is testingGemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanWho this might be right forColorectal Cancer Yonsei University 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03983993What this trial is testingNiraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal CancerWho this might be right forAdvanced Microsatellite Stable Colorectal CarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaMicrosatellite Stable+3 more Emory University 26
Testing effectiveness (Phase 2)Looking for participantsNCT07147231What this trial is testingTesting the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal CancerWho this might be right forMetastatic Colorectal AdenocarcinomaRefractory Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8+2 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)UnknownNCT06575127What this trial is testingModified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two StudyWho this might be right forNeoplasm MalignantColon Cancer Stage 4 Al-Azhar University 60
Testing effectiveness (Phase 2)Study completedNCT00010283What this trial is testingBeclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)UnknownNCT00392470What this trial is testingRadiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerWho this might be right forColorectal Cancer Centre Hospitalier Universitaire Vaudois 20
Early research (Phase 1)Study completedNCT03542214What this trial is testingCalcium Electroporation for the Treatment of Colorectal CancerWho this might be right forColorectal Cancer Stage IV Zealand University Hospital 6
Not applicableUnknownNCT04714814What this trial is testingMechanisms of Fate Evolution of Colorectal Adenocarcinoma MetastasisWho this might be right forColorectal Cancer Stage IIIColorectal Cancer Stage IV Shanghai Minimally Invasive Surgery Center 200
Testing effectiveness (Phase 2)UnknownNCT01675999What this trial is testingTrial of Neoadjuvant Chemotherapy in Locally Advanced Colon CancerWho this might be right forColon CancerLocally Advanced Malignant Neoplasm Assistance Publique - Hôpitaux de Paris 186